B37.32
Chronic candidiasis of vulva and vagina
Clinical Classification Guidelines
Inclusion Terms
- Recurrent candidiasis of vulva and vagina
Medical Intelligence & Overview
Chronic candidiasis of the vulva and vagina is a long-lasting fungal infection caused by an overgrowth of Candida species, most commonly Candida albicans. This condition is characterized by repeated episodes of infection, leading to persistent discomfort and irritation in affected individuals. It is classified under ICD-10 code B37.32 and is recognized for its recurrent nature, often requiring ongoing management. Understanding its causes, symptoms, diagnosis, and treatment options can help those affected better manage the condition and improve quality of life.
Causes & Symptoms
Clinical Causes: Repeated or persistent Candida overgrowth due to imbalance in vaginal flora. Use of antibiotics that disrupt normal bacteria, allowing fungi to proliferate. Hormonal changes associated with pregnancy, menstrual cycle, or hormone therapy. Poor personal hygiene or irritation from soaps, douches, or hygiene products. Diabetes, which can promote fungal growth if blood sugar levels are not well-controlled. A weakened immune system, including conditions like HIV/AIDS or immunosuppressive therapy. Wearing tight, non-breathable clothing that traps moisture and warmth. Repeatedly using topical corticosteroids, which may suppress local immune responses.
Key Symptoms: Persistent or recurrent itching around the vulva and vaginal area. Redness and soreness of the vulval skin. Unusual vaginal discharge that is typically thick, white, and cottage cheese-like. Discomfort or burning sensation during urination or sexual intercourse. Swelling and irritation of the vulva. Possible soreness or discomfort that worsens during episodes of active infection.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a clinical examination of the vulvar and vaginal areas, assessing symptoms, and reviewing medical history. Laboratory tests such as vaginal swabs or cultures are often performed to identify Candida species and differentiate from other infections. Microscopic examination may reveal yeast forms, and sensitivity testing can be done for resistant strains. Due to its recurrent nature, healthcare providers may also consider underlying factors or contributing health conditions.
Treatment Protocols: Managing chronic candidiasis typically involves a combination of antifungal medications and addressing contributing factors. Treatment options include: - **Topical antifungal agents** such as clotrimazole, miconazole, or tioconazole applied directly to affected areas. - **Oral antifungal medications** like fluconazole for more severe or recurrent cases, often prescribed in a specific course. - **Lifestyle modifications:** Wearing loose, breathable clothing, maintaining proper hygiene, and avoiding irritants. - **Managing underlying conditions** such as diabetes or hormone imbalances. - **Probiotics or dietary changes** may be suggested to restore healthy vaginal flora. - **Monitoring and follow-up** are important to prevent recurrence and address persistent issues.
Clinical Advice & FAQs
Billing Guidance
Is B37.32 a billable ICD-10 code?
Yes, B37.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B37.32?
Clinical documentation must specify the nature of Chronic candidiasis of vulva and vagina and any associated comorbidities for accurate reporting.
Cite this Clinical Reference